BIOPX
Price
$61.01
Change
-$0.42 (-0.68%)
Updated
Jul 2 closing price
Net Assets
2.07B
RGAEX
Price
$85.57
Change
-$0.84 (-0.97%)
Updated
Jul 2 closing price
Net Assets
360.63B
Interact to see
Advertisement

BIOPX vs RGAEX

BIOPX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
BIOPX vs. RGAEX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOPX is a Hold and RGAEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 361B vs. BIOPX (2.07B). RGAEX pays higher dividends than BIOPX: RGAEX (0.21) vs BIOPX (0.00). BIOPX was incepted earlier than RGAEX: BIOPX (26 years) vs RGAEX (24 years). BIOPX (1.31) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. BIOPX (30.00). RGAEX has a lower initial minimum investment than BIOPX: RGAEX (250) vs BIOPX (2000). BIOPX annual gain was more profitable for investors over the last year : 20.91 vs. RGAEX (5.99). BIOPX return over 5 years is better than : 37.47 vs. RGAEX (15.59).
BIOPXRGAEXBIOPX / RGAEX
Total Expense Ratio1.310.63208%
Annual Report Gross Expense Ratio1.310.63208%
Fund Existence26 years24 years-
Gain YTD13.0027.866165%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B361B1%
Annual Yield % from dividends0.000.21-
Returns for 1 year20.915.99349%
Returns for 3 years87.8443.35203%
Returns for 5 years37.4715.59240%
Returns for 10 years283.47109.56259%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEICX6.510.08
+1.24%
Gabelli Equity Income C
NQVRX74.170.52
+0.71%
Nuveen Multi Cap Value I
TRAIX38.090.04
+0.11%
T. Rowe Price Capital Appreciation I
AIBBX16.920.01
+0.06%
Aristotle Small Cap Equity I-2
CEMVX18.37-0.38
-2.03%
Causeway Emerging Markets Investor